JB Chem sells OTC biz in Russia/CIS to J&J arm for Rs 938 cr

24 May 2011 Evaluate


JB Chemicals and Pharmaceuticals Ltd has approved the sale of its over the counter business in Russia and CIS countries to Cilag GmbH International, a wholly owned subsidiary of Johnson & Johnson. The consideration for this transaction is Rs 938 crore. Including the sale of trademarks, registration, brands etc, the total consideration of the deal is about Rs 1,155 crore, and the deal is expected to be completed in two months.

The Russia/CIS OTC business is being sold as a going concern on a slump sale basis including OTC trademarks, brands, patents, registrations and domain names. The sale will also involve the transfer of the employees (about 220 people) of the Russia/CIS OTC business.

Cilag's affiliate, Johnson & Johnson LLC, has also entered into a contract with the company's wholly owned subsidiary situated in Russia for purchase of its OTC inventory and receivables for a consideration of $47 million (Rs 211crore).

crackcrack

JB Chem & Pharma Share Price

1823.95 0.85 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×